MAXLINEAR, INC·4

May 22, 5:35 PM ET

ARTUSI DANIEL A 4

4 · MAXLINEAR, INC · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

MaxLinear (MXL) Director Daniel Artusi Receives RSU Award

What Happened

  • Daniel Artusi, a director of MaxLinear, was granted 1,963 restricted stock units (RSUs) on 2026-05-20. The award is reported as a derivative grant (code A) at $0.00 per unit — i.e., no cash purchase. Each RSU represents a contingent right to one share of MaxLinear common stock.

Key Details

  • Transaction date: 2026-05-20; Form 4 filed: 2026-05-22.
  • Amount: 1,963 RSUs; reported price: $0.00 (award/grant).
  • Vesting: 100% of the RSUs vest on the earlier of May 1, 2027 or the day before the next annual meeting of stockholders, provided Artusi continues as a director (per footnotes F1 and F2).
  • Shares owned after transaction: not specified in the provided filing details.
  • Filing timeliness: Form 4 was filed two days after the grant date (appears within the common two-business-day window).

Context

  • RSUs are a form of equity compensation that convert into shares if vesting conditions are met; this is not an open-market purchase or sale and does not immediately change share count until vesting and settlement occur.
  • Such awards are commonly used to align directors with shareholder interests; they are procedural compensation rather than a direct market sentiment signal.

Insider Transaction Report

Form 4
Period: 2026-05-20
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-05-20+1,9631,963 total
    Common Stock (1,963 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
  • [F2]Subject to the Reporting Person's continuing as a Director (as defined in the 2010 Equity Incentive Plan) through such date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of May 1, 2027 or the date immediately preceding the next annual meeting of stockholders.
Signature
/s/ Connie Kwong, as Attorney-in-Fact|2026-05-22

Documents

1 file
  • 4
    wk-form4_1779485747.xmlPrimary

    FORM 4